Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Cancer Research
|
December 18, 2003
In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation
Xinghua Sun, Zhijian Yang, Shukuan Li, et al.
Cancer Research
|
August 18, 2004
Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate
Zhijian Yang, Xinghua Sun, Shukuan Li, et al.
Cell Cycle (Georgetown, Tex.)
|
April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Cancer Letters
|
June 22, 2018
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Oncotarget
|
September 15, 2017
Toxicology and efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice
Yong Zhang, Wenluo Cao, Makoto Toneri, et al.
Anticancer Research
|
October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
February 27, 2026
Ultra-low Concentrations of Cisplatinum Down to the IC<sub>10</sub> in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse Model
Yohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Oncotarget
|
November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Cancer Research
|
December 18, 2003
In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation
Xinghua Sun, Zhijian Yang, Shukuan Li, et al.
Cancer Research
|
August 18, 2004
Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate
Zhijian Yang, Xinghua Sun, Shukuan Li, et al.
Cell Cycle (Georgetown, Tex.)
|
April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Cancer Letters
|
June 22, 2018
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Oncotarget
|
September 15, 2017
Toxicology and efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice
Yong Zhang, Wenluo Cao, Makoto Toneri, et al.
Anticancer Research
|
October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
February 27, 2026
Ultra-low Concentrations of Cisplatinum Down to the IC<sub>10</sub> in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)
|
June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse Model
Yohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Oncotarget
|
November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Page
of 6